New insights into the mediators of patient recovery after CAR T cell immunotherapy
Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read more
Clinical Trials
De-escalating breast cancer therapy; can some patients be spared chemotherapy?
About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive
Read more
From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read more
How genomics profiling can help identify the best treatment for bladder cancer
When it comes to cancer, one-size-does-not-fit-all. “One of the challenges that we have when taking care of patients with bladder cancer is that from one
Read more
Is there really a perfect way to study humans?
Doctors, patients, and researchers are frustrated when a new healthcare approach works well in a study, but then has disappointing results in the “real world.”
Read more
Fighting back lymphoma resistance to treatment
T cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read moreBaylor College of Medicine investigates bird flu vaccine
This time of year, there’s always a lot of discussion about the flu – vaccines, outbreaks, comparisons to previous years, and more. It wasn’t too
Read more